Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Wright Medical Group Inc Lowers FY 2013 Guidance-Conference Call


Monday, 5 Aug 2013 04:30pm EDT 

Wright Medical Group Inc announced that it expects fiscal 2013 net sales from continuing operations (or Extremities and Biologics revenue) to be approximately $235-240 million and diluted adjusted EPS from continuing operations (based on approximately 45.3 million shares outstanding and including stock-based compensation) to be $0.55-0.59. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $490 million and EPS of $(0.28) for fiscal 2013. 

Company Quote

27.98
-0.04 -0.14%
9:53am EST